Post-Treatment Lyme Disease: Clinical Trials

1 trial for Post-Treatment Lyme Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Post-Treatment Lyme Disease: new trials by email Literature Review of Post-Treatment Lyme Disease trials Research Report on Post-Treatment Lyme Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tetracycline Treatment Tolerability Trial
Tetracycline 500 Mg, Placebo - Post-Treatment Lyme Disease
Phase 2CompletedJohns Hopkins University602022-11-022026-09-28

Narrower conditions

Post-Lyme Disease Syndrome (1)

Broader conditions

Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Borrelia Infections (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Infections (1)  ·  Lyme Disease (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Post-Infectious Disorders (1)  ·  Spirochaetales Infections (1)  ·  Tick-Borne Diseases (1)  ·  Vector Borne Diseases (1)

Interventions

Tetracycline (1)

Sponsors

Johns Hopkins University (1)

Countries

United States (1)

Top investigators

John N. Aucott, MD (1)